Clinical trial
Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II…
NCT00194116 · University Hospitals Cleveland Medical Center, Other · Completed
Key facts
| NCT number | NCT00194116 |
|---|---|
| Title | Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression |
| Official title | Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression |
| Lead sponsor | University Hospitals Cleveland Medical Center, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Divalproex Sodium ER, Placebo |
| Enrollment | 54 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Jul 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: